← Leaderboards
Sumeet Seth
Evon Medics, Llc
$2,844,919
Attributed
$7,694,763
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2018–24$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,694,763 · 4
By mechanism
R44$7,244,763 · 3
R43$450,000 · 1
Top collaborators
- Evaristus A Nwulia12 shared
- Charles Chiedu Nwaokobia8 shared
- Thomas O Obisesan2 shared
Most similar at Evon Medics, Llc
Same institution · by research overlap
- Charles Chiedu Nwaokobia$4,402,384
- Evaristus A Nwulia$14,602,860
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposEvaluationOlfactory CortexTrainingProgramsPortabilityDevicesComputerizedInnovationFeedbackEffectivenessBaseSmall Business Innovation Research GrantStimulant UseEfficacy StudyPsychophysicsServicesSiteLeadRandomized TrialDesignAdultOdorsPharmaceutical Preparations
Grant awards (12)
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,219,088
R44 · FY2024 · DA
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,318,829
R44 · FY2023 · DA
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$55,000
R44 · FY2023 · DA
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$1,245,116
R44 · FY2022 · AG · contact PI
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$330,680
R44 · FY2022 · DA
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease$98,280
R44 · FY2022 · AG · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$50,000
R44 · FY2022 · AG · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$1,247,784
R44 · FY2021 · AG · contact PI
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder$859,103
R44 · FY2021 · DA · contact PI
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder$820,883
R44 · FY2020 · DA · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$225,000
R43 · FY2019 · AG · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$225,000
R43 · FY2018 · AG · contact PI